Ascential Medical & Life Sciences, a leader in end-to-end solutions for complex medical and life science devices that provides total commercialization services from ideation to scaled manufacturing, today announced three key executive leadership changes that will play an integral role in positioning the company for its next phase of growth. Ellen Scipta has been appointed Chief Financial Officer (CFO), Todd Martensen has transitioned from Chief Commercial Officer (CCO) to Chief Strategy Officer (CSO), and Christopher Cowen has assumed the role of CCO. This strategic leadership evolution strengthens the company's ability to execute its vision and further solidifies its place as an industry leader.
As CFO, Ellen will oversee the company's financial strategy, drive operational efficiencies and support its continued growth within the medical and life sciences sector. She brings more than two decades of experience leading financial operations, transforming organizations and navigating complex business challenges. She has a proven track record of uniting teams to achieve organizational goals and an unwavering commitment to integrity, value and operational excellence. Ellen's experience spans public, private and consulting sectors including significant tenure in global life sciences and consumer products companies such as Bio-Technie and Best Buy. Prior to joining Ascential Medical & Life Sciences, she was managing director at Riveron Consulting, a national business advisory firm, where she focused on financial planning and analysis (FP&A), financial reporting, financial technology and client solutions.
"Ellen's deep financial expertise and energetic leadership style will be invaluable as we continue to scale our operations and identify streamlined ways to support our customers," said Anupam Girdhar, CEO of Ascential Medical & Life Sciences. "Her strategic vision and get-things-done approach align with our mission of continuing to unlock performance for mission-critical companies."
Additionally, Todd has transitioned from his role as CCO to CSO to lead the company's strategic direction and long-term growth initiatives. In this instrumental position, Todd will play a pivotal role in advancing the company's position as a leader in the medical and life sciences industry by fostering innovation, partnerships, mergers and acquisitions (M&A) and strategic investments while unlocking new market segments and growth areas. For the last two years, Todd has been a vital part of Ascential Medical & Life Sciences' success. He brings more than three decades of experience in commercial leadership, strategic planning and operations and a strong vision for expansion and innovation.
"Todd's passion and commitment to operational excellence has been instrumental in our recent momentum, and we are confident that he will thrive in his new role as CSO," said Anupam. "His expertise in setting strategic direction and identifying organic and inorganic growth opportunities will help further scale Ascential Medical & Life Sciences and open doors for the company to make an even bigger impact in the healthcare industry."
Comments powered by CComment